Loading candles…
IOL Chemicals & Pharmaceuticals Ltd operates in the pharmaceuticals and specialty chemicals industries, producing active pharmaceutical ingredients (APIs) and specialty chemicals for both domestic and export markets. The company is notably the largest global producer of Ibuprofen, holding a 35% share of the world market, and is distinguished as the only company worldwide with complete backward integration for the Ibuprofen API. Its product range includes Ibuprofen as well as chemical products used in the food processing, textiles, and paints industries. Serving the domestic Indian market as well as global export markets, IOL Chemicals & Pharmaceuticals Ltd plays a significant role in its sectors. No information on incorporation year, founders, key management personnel, subsidiaries, or stock exchange listings is provided.
This page is a live market overview for IOL CHEM AND PHARMA LTD (IOLCP) on the NSE. As a listed security, IOL CHEM AND PHARMA LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for IOLCP before placing trades on tick2trade.
As of the latest feed, IOLCP last traded at ₹167.85 on NSE, up ₹4.67 (2.86%) from the previous close of ₹163.18. Today's session range is ₹163.35 – ₹171, against a 52-week band of ₹67.19 – ₹179.6. Traded volume today stands at 45.29L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for IOLCP in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether IOLCP is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for IOL CHEM AND PHARMA LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in IOLCP. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated IOLCP option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 10 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 | 20 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and to consider declaration of Interim Dividend for FY 2025-26 | 11 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 11 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 7 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 16 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.